Senior Director, Clinical Value & Access, Screening (East US)

Company Description

Guardant Health is a leading precision oncology company focused on guarding wellness and giving every person more time free from cancer. Founded in 2012, Guardant is transforming patient care and accelerating new cancer therapies by providing critical insights into what drives disease through its advanced blood and tissue tests, real-world data and AI analytics. Guardant tests help improve outcomes across all stages of care, including screening to find cancer early, monitoring for recurrence in early-stage cancer, and treatment selection for patients with advanced cancer. For more information, visit guardanthealth.com and follow the company on LinkedIn, X (Twitter) and Facebook.

Job Description

The Senior Director, Clinical Value and Access, Screening is a subject matter expert and key senior team member who embraces the challenge to lead an innovative approach to cancer screening.

The Senior Director, Clinical Value and Access, Screening is a medical affairs professional who can leverage deep clinical training and commercial experience to develop key partnerships with stakeholders within the cancer screening healthcare ecosystem for Guardant Health.

The Senior Director, Clinical Value and Access, Screening will engage leading healthcare professionals, working with them to support the appropriate introduction of new cancer screening products and services. The Senior Director, Clinical Value and Access, Screening has deep scientific and commercial background and knowledge within the oncology diagnostics space, authoritatively communicating and working collaboratively with leading healthcare professionals to demonstrate and gain recognition for the clinical and economic value of Guardant Health’s screening product(s) and services.

Responsibilities

• Effective at translating data from research and publications and disseminating information through publications, presentations at national meetings and Continuing Medical Education (CME) and educational activities.
• Engage with key leaders in cancer screening focusing on target medical systems to discuss evidence for blood-based Colorectal Cancer (CRC) screening that supports adoption and explore current screening pathways for CRC. Work with these medical systems in developing unique performance data to demonstrate the impact of screening products on clinical outcomes.
• Engage C-suite executives within medical systems and organizations including Chief Medical Officers and Chief Quality Officers.
• Consult with Investigators on data collection, regulatory questions, and protocol development as it pertains to Guardant Health screening assays in collaboration with VP, Clinical Development, Screening and VP, Medical Affairs, Screening.
• Develop new external partnerships that drive and accelerate adoption of our screening products through collaboration with internal stakeholders.
• Facilitate meetings and scientific opportunities that initiate and strengthen relationships with KOLs and other key physician influencers.
• Support on-site oral presentations, data reviews, and interactive education events for KOLs, also known as “deep dive” or “VIP” visits to Guardant Health.
• An active participant in the broader Medical Affairs organization (MACDOERS) providing valuable input into the wider organization. Collaborating and supporting the engagement of the wider Screening Medical Affairs and Commercial organizations.
• Up to 50% regional travel expected.

Qualifications

• Advanced degree (MS, MPH, PhD, PharmD, MD) with 10+ years of experience in medical affairs strongly desired. 5+ years of experience in diagnostics, oncology, screening, public health or other adjacent field preferred.
• Ability to work effectively in a fast-paced, constantly evolving, rapidly growing environment with strong interp